Research ExplorerScientific StaffAngela Schulz

Dr.med. ID: 55805

Angela Schulz

graph of relations
Affiliations

Publications

The parent and family impact of CLN3 disease: an observational survey-based study

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Language Delay in Patients with CLN2 Disease: Could It Support Earlier Diagnosis?

Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

Ongoing retinal degeneration despite intraventricular enzyme replacement therapy with cerliponase alfa in late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease)

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Visual perception and macular integrity in non-classical CLN2 disease

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Natural history of MRI brain volumes in patients with neuronal ceroid lipofuscinosis 3: a sensitive imaging biomarker

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Therapeutic Management of COVID-19 in a Pediatric Patient with Neurodegenerative CLN2 Disease and ICV-Enzyme Replacement Therapy: A Case Report

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

The Unified Batten Disease Rating Scale (UBDRS): Validation and reliability in an independent CLN3 disease sample

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Natural History Studies in NCL and Their Expanding Role in Drug Development: Experiences From CLN2 Disease and Relevance for Clinical Trials

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Development of the "Hamburg Best Practice Guidelines for ICV-Enzyme Replacement therapy (ERT) in CLN2 Disease" Based on 6 Years Treatment Experience in 48 Patients

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (57)

projects

01GM1516A BMBF - DLR - NCL2TREAT

Project: Research

281234 DEM-Child (A

Project: Research

SCHU 1597/2-2 Klinik

Project: Research

View all (3)